The BlotCycler automates western blot development and processing. BlotCycler, automated western processor, will process the blot through all washing, blocking, and incubation steps. Once the ...

The system allows to program the automatic reagent distribution (from 1 to 7 in the standard version or from 1 to 13 as option). The shaking operation, made through the worktop oscillation can be ...

Once again, the ease of use, precision and reproducibility offered by our Simple Western automated Western blood instrument, our Simple Plex automated multiplexing immunoassay system, and our ...

Now let's discuss our protein analysis growth pillar, where we experienced strong sales momentum across our portfolio of automated workflow solutions. Once again, the ease of use, precision and ...

Automatic Data Processing, Inc. (NASDAQ:ADP) came out with its quarterly results last week, and we wanted to see how the business is performing and what industry forecasters think of the company ...

In other Automatic Data Processing news, CEO Maria Black sold 721 shares of the business’s stock in a transaction on Friday, January 3rd. The shares were sold at an average price of $291.59, for ...

In recent trading, shares of Automatic Data Processing Inc. (Symbol: ADP) have crossed above the average analyst 12-month target price of $300.67, changing hands for $303.26/share. When a stock ...

In a report released yesterday, Ashish Sabadra from RBC Capital maintained a Hold rating on Automatic Data Processing (ADP – Research Report), with a price target of $315.00. The company’s ...

(RTTNews) - Automatic Data Processing Inc. (ADP) reported a profit for its second quarter that increased from last year and beat the Street estimates. The company's earnings came in at $963.2 ...

In this article, we are going to take a look at where Automatic Data Processing, Inc. (NASDAQ:ADP) stands against other best dividend stocks to buy and hold. In recent years, many investors have ...

Automatic Data Processing has benefited from increased demand for HCM solutions post-COVID-19, while maintaining high liquidity and cautious market expansion to sustain growth and minimize risks.